Improve Medical(300030)2023-07-24 12:11Group 1: Company Overview - Yangpu Medical Technology Co., Ltd. is focused on molecular diagnostics and has made significant investments in this area since 2021 [1] - The company has a competitive advantage in molecular diagnostic products, featuring advanced technology and high automation, which reduces human error [1] Group 2: Sales Channels - Domestic direct sales account for approximately 25% of the sales of vacuum blood collection tubes, while distribution channels make up about 75% [2] - The primary sales focus for vacuum blood collection tubes is hospitals, supplemented by third-party testing institutions [2] Group 3: Product Certification and Market Reach - The company holds multiple certifications including EU CE, US FDA, and market access qualifications in Canada, Brazil, and over 100 other countries [2] - The quality management system meets various international standards such as ISO9001, ISO13485, and others, serving nearly 10,000 well-known medical institutions globally [2] Group 4: Research and Development - In 2022, the company's R&D investment accounted for 6.14% of revenue, an increase of 0.61 percentage points from the previous year [2] - The company received 24 new patent authorizations in 2022, including 3 domestic invention patents and 20 utility model patents [2] - Ongoing projects include the development of an AI-based automatic thromboelastography system and a molecular diagnostic blood collection tube project [2]